APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

RSV Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global RSV Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174033600321 December 2025188 pages

Choose your research edition.

Industry ResearchRSV Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal RSV Vaccine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal RSV Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RSV Vaccine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal RSV Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global RSV Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for RSV Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for RSV Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for RSV Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for RSV Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of RSV Vaccine include Nuance Pharma, Pfizer, GSK, Advaccine, Moderna, JNJ and Bavarian Nordic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global RSV Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of RSV Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents RSV Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the RSV Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

RSV Vaccine Segment by Company

Nuance Pharma

Pfizer

GSK

Advaccine

Moderna

JNJ

Bavarian Nordic

RSV Vaccine Segment by Type

Being Developed

Preclinical

Clinical III

Clinical II

Clinical I

RSV Vaccine Segment by Application

Elderly Vaccine

Infant Vaccine

Others

RSV Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RSV Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RSV Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RSV Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the RSV Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of RSV Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of RSV Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of RSV Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. RSV Vaccine Industry Trends Table 2. RSV Vaccine Industry Drivers Table 3. RSV Vaccine Industry Opportunities and Challenges Table 4. RSV Vaccine Industry Restraints Table 5. Global RSV Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global RSV Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global RSV Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global RSV Vaccine Sales Market Share by Manufacturers Table 9. Global RSV Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global RSV Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global RSV Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global RSV Vaccine Manufacturers, Product Type & Application Table 13. Global RSV Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global RSV Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Being Developed Table 17. Major Manufacturers of Preclinical Table 18. Major Manufacturers of Clinical III Table 19. Major Manufacturers of Clinical II Table 20. Major Manufacturers of Clinical I Table 21. Global RSV Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global RSV Vaccine Sales by Type (2021-2026) & (k units) Table 23. Global RSV Vaccine Sales by Type (2027-2032) & (k units) Table 24. Global RSV Vaccine Sales Market Share by Type (2021-2026) Table 25. Global RSV Vaccine Sales Market Share by Type (2027-2032) Table 26. Global RSV Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global RSV Vaccine Revenue by Type (2021-2026) & (k units) Table 28. Global RSV Vaccine Revenue by Type (2027-2032) & (k units) Table 29. Global RSV Vaccine Revenue Market Share by Type (2021-2026) Table 30. Global RSV Vaccine Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Elderly Vaccine Table 32. Major Manufacturers of Infant Vaccine Table 33. Major Manufacturers of Others Table 34. Global RSV Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global RSV Vaccine Sales by Application (2021-2026) & (k units) Table 36. Global RSV Vaccine Sales by Application (2027-2032) & (k units) Table 37. Global RSV Vaccine Sales Market Share by Application (2021-2026) Table 38. Global RSV Vaccine Sales Market Share by Application (2027-2032) Table 39. Global RSV Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global RSV Vaccine Revenue by Application (2021-2026) & (k units) Table 41. Global RSV Vaccine Revenue by Application (2027-2032) & (k units) Table 42. Global RSV Vaccine Revenue Market Share by Application (2021-2026) Table 43. Global RSV Vaccine Revenue Market Share by Application (2027-2032) Table 44. Global RSV Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global RSV Vaccine Sales by Region (2021-2026) & (k units) Table 46. Global RSV Vaccine Sales Market Share by Region (2021-2026) Table 47. Global RSV Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global RSV Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 49. North America RSV Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America RSV Vaccine Sales by Country (2021-2026) & (k units) Table 51. North America RSV Vaccine Sales by Country (2027-2032) & (k units) Table 52. Europe RSV Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe RSV Vaccine Sales by Country (2021-2026) & (k units) Table 54. Europe RSV Vaccine Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific RSV Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific RSV Vaccine Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific RSV Vaccine Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa RSV Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa RSV Vaccine Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa RSV Vaccine Sales by Country (2027-2032) & (k units) Table 61. Global RSV Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global RSV Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 63. Global RSV Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 64. Global RSV Vaccine Revenue Market Share by Region (2021-2026) Table 65. Global RSV Vaccine Revenue Market Share by Region (2027-2032) Table 66. Nuance Pharma Company Information Table 67. Nuance Pharma Business Overview Table 68. Nuance Pharma RSV Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Nuance Pharma RSV Vaccine Product Portfolio Table 70. Nuance Pharma Recent Development Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer RSV Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Pfizer RSV Vaccine Product Portfolio Table 75. Pfizer Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK RSV Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. GSK RSV Vaccine Product Portfolio Table 80. GSK Recent Development Table 81. Advaccine Company Information Table 82. Advaccine Business Overview Table 83. Advaccine RSV Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Advaccine RSV Vaccine Product Portfolio Table 85. Advaccine Recent Development Table 86. Moderna Company Information Table 87. Moderna Business Overview Table 88. Moderna RSV Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Moderna RSV Vaccine Product Portfolio Table 90. Moderna Recent Development Table 91. JNJ Company Information Table 92. JNJ Business Overview Table 93. JNJ RSV Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. JNJ RSV Vaccine Product Portfolio Table 95. JNJ Recent Development Table 96. Bavarian Nordic Company Information Table 97. Bavarian Nordic Business Overview Table 98. Bavarian Nordic RSV Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Bavarian Nordic RSV Vaccine Product Portfolio Table 100. Bavarian Nordic Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. RSV Vaccine Distributors List Table 104. RSV Vaccine Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. RSV Vaccine Product Image Figure 2. Global RSV Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global RSV Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global RSV Vaccine Sales (2021-2032) & (k units) Figure 5. Global RSV Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 RSV Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Being Developed Image Figure 9. Preclinical Image Figure 10. Clinical III Image Figure 11. Clinical II Image Figure 12. Clinical I Image Figure 13. Global RSV Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global RSV Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global RSV Vaccine Sales Market Share by Type (2021-2032) Figure 16. Global RSV Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global RSV Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global RSV Vaccine Revenue Market Share by Type (2021-2032) Figure 19. Elderly Vaccine Image Figure 20. Infant Vaccine Image Figure 21. Others Image Figure 22. Global RSV Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global RSV Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global RSV Vaccine Sales Market Share by Application (2021-2032) Figure 25. Global RSV Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global RSV Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global RSV Vaccine Revenue Market Share by Application (2021-2032) Figure 28. North America RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America RSV Vaccine Sales Market Share by Country (2021-2032) Figure 30. U.S. RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe RSV Vaccine Sales Market Share by Country (2021-2032) Figure 35. Germany RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. France RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific RSV Vaccine Sales Market Share by Country (2021-2032) Figure 42. China RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 46. India RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa RSV Vaccine Sales Market Share by Country (2021-2032) Figure 50. Brazil RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile RSV Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global RSV Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global RSV Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America RSV Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. North America RSV Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe RSV Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. Europe RSV Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific RSV Vaccine Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific RSV Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa RSV Vaccine Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa RSV Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. RSV Vaccine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. RSV Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Being Developed
  • Preclinical
  • Clinical III
  • Clinical II
  • Clinical I
Applications
  • Elderly Vaccine
  • Infant Vaccine
  • Others
Companies covered
  • Nuance Pharma
  • Pfizer
  • GSK
  • Advaccine
  • Moderna
  • JNJ
  • Bavarian Nordic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global RSV Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global RSV Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global RSV Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global RSV Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global RSV Vaccine Market Dynamics
  1. 2.1 RSV Vaccine Industry Trends
  2. 2.2 RSV Vaccine Industry Drivers
  3. 2.3 RSV Vaccine Industry Opportunities and Challenges
  4. 2.4 RSV Vaccine Industry Restraints
3 RSV Vaccine Market by Manufacturers
  1. 3.1 Global RSV Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global RSV Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global RSV Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global RSV Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global RSV Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global RSV Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global RSV Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global RSV Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 RSV Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 RSV Vaccine Tier 1, Tier 2, and Tier 3
4 RSV Vaccine Market by Type
  1. 4.1 RSV Vaccine Type Introduction
  2. 4.1.1 Being Developed
  3. 4.1.2 Preclinical
  4. 4.1.3 Clinical III
  5. 4.1.4 Clinical II
  6. 4.1.5 Clinical I
  7. 4.2 Global RSV Vaccine Sales by Type
  8. 4.2.1 Global RSV Vaccine Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global RSV Vaccine Sales by Type (2021-2032)
  10. 4.2.3 Global RSV Vaccine Sales Market Share by Type (2021-2032)
  11. 4.3 Global RSV Vaccine Revenue by Type
  12. 4.3.1 Global RSV Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global RSV Vaccine Revenue by Type (2021-2032)
  14. 4.3.3 Global RSV Vaccine Revenue Market Share by Type (2021-2032)
5 RSV Vaccine Market by Application
  1. 5.1 RSV Vaccine Application Introduction
  2. 5.1.1 Elderly Vaccine
  3. 5.1.2 Infant Vaccine
  4. 5.1.3 Others
  5. 5.2 Global RSV Vaccine Sales by Application
  6. 5.2.1 Global RSV Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global RSV Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global RSV Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global RSV Vaccine Revenue by Application
  10. 5.3.1 Global RSV Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global RSV Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global RSV Vaccine Revenue Market Share by Application (2021-2032)
6 Global RSV Vaccine Sales by Region
  1. 6.1 Global RSV Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global RSV Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global RSV Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global RSV Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America RSV Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America RSV Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe RSV Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe RSV Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific RSV Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific RSV Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa RSV Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa RSV Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global RSV Vaccine Revenue by Region
  1. 7.1 Global RSV Vaccine Revenue by Region
  2. 7.1.1 Global RSV Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global RSV Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global RSV Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global RSV Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America RSV Vaccine Revenue (2021-2032)
  8. 7.2.2 North America RSV Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe RSV Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe RSV Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific RSV Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific RSV Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa RSV Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa RSV Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Nuance Pharma
  2. 8.1.1 Nuance Pharma Company Information
  3. 8.1.2 Nuance Pharma Business Overview
  4. 8.1.3 Nuance Pharma RSV Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Nuance Pharma RSV Vaccine Product Portfolio
  6. 8.1.5 Nuance Pharma Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer RSV Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer RSV Vaccine Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK RSV Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GSK RSV Vaccine Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Advaccine
  20. 8.4.1 Advaccine Company Information
  21. 8.4.2 Advaccine Business Overview
  22. 8.4.3 Advaccine RSV Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Advaccine RSV Vaccine Product Portfolio
  24. 8.4.5 Advaccine Recent Developments
  25. 8.5 Moderna
  26. 8.5.1 Moderna Company Information
  27. 8.5.2 Moderna Business Overview
  28. 8.5.3 Moderna RSV Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Moderna RSV Vaccine Product Portfolio
  30. 8.5.5 Moderna Recent Developments
  31. 8.6 JNJ
  32. 8.6.1 JNJ Company Information
  33. 8.6.2 JNJ Business Overview
  34. 8.6.3 JNJ RSV Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 JNJ RSV Vaccine Product Portfolio
  36. 8.6.5 JNJ Recent Developments
  37. 8.7 Bavarian Nordic
  38. 8.7.1 Bavarian Nordic Company Information
  39. 8.7.2 Bavarian Nordic Business Overview
  40. 8.7.3 Bavarian Nordic RSV Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bavarian Nordic RSV Vaccine Product Portfolio
  42. 8.7.5 Bavarian Nordic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 RSV Vaccine Value Chain Analysis
  2. 9.1.1 RSV Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 RSV Vaccine Production Mode & Process
  6. 9.2 RSV Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 RSV Vaccine Distributors
  9. 9.2.3 RSV Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst